Warning: The NCBI web site requires JavaScript to function. more...
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P; QUARTET Study Group.
Diabet Med. 2005 Apr;22(4):399-405.PMID: 15787663 [PubMed - indexed for MEDLINE]Related articles
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G.
Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):167-74.PMID: 15386821 [PubMed - indexed for MEDLINE]Related articles
One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.
Diabetes Care. 2004 Jan;27(1):141-7.PMID: 14693980 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...